About Industrial Pharmacy II
Subject Code
BP702T
Semester
Semester 7
Credits
4 Credits
Industrial Pharmacy II (BP702T) bridges pharmaceutical manufacturing with regulatory and quality systems. It covers pilot plant scale-up techniques (transitioning from lab to production), technology transfer (WHO guidelines, TT agencies), regulatory affairs (IND/NDA drug approval pathways, clinical trials, FDA submissions), quality management systems (TQM, QbD, Six Sigma, ISO standards), and Indian regulatory requirements (CDSCO, State Licensing Authority, COPP). This subject prepares students for careers in pharmaceutical manufacturing, regulatory affairs, and quality management.
Key Learning Objectives
- Scale-Up: Understand pilot plant considerations for solids, liquids, semi-solids, and SUPAC guidelines.
- Technology Transfer: Apply WHO guidelines for transferring processes from R&D to production.
- Regulatory Affairs: Know IND/NDA application processes and clinical trial requirements.
- Quality Systems: Implement TQM, QbD, Six Sigma, and ISO standards in pharmaceutical settings.
- Indian Regulations: Understand CDSCO organization, new drug approval, and COPP certification.
Syllabus & Topics Covered
Unit 1: Pilot Plant Scale-Up Techniques
- General considerations: personnel, space, raw materials.
- Scale-up for solids, liquid orals, and semi-solids.
- Documentation, SUPAC guidelines, platform technology.
Unit 2: Technology Development & Transfer
- WHO guidelines for Technology Transfer: terminology, protocol, QRM.
- Transfer from R&D to production: process, packaging, cleaning.
- TT agencies in India: APCTD, NRDC, TIFAC, BCIL, TBSE/SIDBI.
- Documentation: confidentiality agreements, licensing, MoUs.
Unit 3: Regulatory Affairs & Drug Approval
- Regulatory Affairs: history, authorities, department role.
- Drug development: non-clinical, pharmacology, toxicology.
- IND application, Investigator’s Brochure, NDA.
- Clinical trials, bioequivalence, biostatistics, FDA submissions.
Unit 4: Quality Management Systems
- TQM, QbD, Six Sigma, OOS, Change control.
- ISO 9000 series, ISO 14000, NABL, GLP.
Unit 5: Indian Regulatory Requirements
- CDSCO: organization, responsibilities.
- State Licensing Authority.
- COPP, regulatory requirements for new drug approval.
How to Score High in Industrial Pharmacy II
- 1
SUPAC Categories: Remember the three SUPAC levels (1, 2, 3) and what each requires — this is a guaranteed question.
- 2
IND vs NDA: Create a comparison table of IND and NDA — contents, when filed, who files, what happens after submission.
- 3
Scale-Up Equations: For tablets, know the scale-up parameters (mixer speed, granulator capacity, tablet press output). For liquids, know mixing time × RPM relationships.
- 4
TT Flowchart: Draw the complete technology transfer flow from R&D → pilot plant → production with all documentation at each stage.
Why it Matters for Career
Industrial Pharmacy II directly prepares you for the most in-demand pharmaceutical industry roles: Production Manager, Regulatory Affairs Officer, Quality Management Professional, Technology Transfer Specialist, and Clinical Research Associate. Understanding scale-up, regulatory submissions, and quality systems is essential for any career in pharmaceutical manufacturing or regulatory compliance.
Exam Weightage
Unit 1 (Pilot plant scale-up, SUPAC) and Unit 3 (Regulatory affairs, IND/NDA) are the highest-yield units. Unit 2 (Technology transfer) and Unit 4 (Quality management — TQM, QbD, Six Sigma) are also frequently examined. Unit 5 (CDSCO) is important for short-answer questions.
Frequently Asked Questions (FAQs)
How is Industrial Pharmacy II different from Industrial Pharmacy I?
IP-I (Semester 5, BP504T) focuses on DOSAGE FORM manufacturing — tablets (compression, coating), capsules, liquid orals, parenterals, packaging. IP-II (Semester 7, BP702T) focuses on the SYSTEMS around manufacturing — how to scale up from lab to production (pilot plant), how to transfer technology, how to get regulatory approval (IND/NDA), quality management systems (TQM, QbD), and Indian regulatory requirements (CDSCO). IP-I = the ‘what’ (products). IP-II = the ‘how’ (systems, processes, regulations).
Is this subject important for regulatory affairs career?
Absolutely — this is THE foundational subject for a regulatory affairs career. It covers IND/NDA applications, clinical trial regulations, FDA submission formats, CDSCO requirements, and quality management systems — all core competencies for regulatory affairs professionals. Companies like Cipla, Dr. Reddy’s, Sun Pharma actively hire regulatory affairs specialists, and the knowledge from this subject is directly tested in regulatory affairs interviews.
What is SUPAC and why is it important?
SUPAC (Scale-Up and Post-Approval Changes) is an FDA guidance that classifies manufacturing changes after product approval into levels based on their impact on product quality. Level 1: minor changes (unlikely to affect quality) — minimal documentation. Level 2: moderate changes (could affect quality) — additional testing needed. Level 3: major changes (likely to affect quality) — full-scale stability and bioequivalence studies required. SUPAC is important because it provides a structured framework for making manufacturing changes without re-filing a full NDA.